This research demonstrates a Schiff base chemosensor’s ability to detect Cu2+ ions selectively, indicating anti-Alzheimer capability.
In this work, a Schiff base chemosensor (6-hydroxy-N′-(pyren-1-ylmethylene)-2-naphthohydrazide) (HL) was synthesized, which can be used for the detection of Cu2+. This shows excellent selectivity towards Cu2+ ions at pH 7.4. The association constant (Ka) of the chemosensor for binding with Cu2+ was 1.16 × 104 M–1. Using the Benesi–Hildebrand relation, the stoichiometric ratio for complexation was found to be 1:1. The DFT method, the B3LYP functional and the 6-311++G(d,p) basis set were employed to calculate the frontier molecular orbital (FMO) analysis and molecular electrostatic potential (MEP). Based on the docking investigation, the Schiff base exhibits the anti-Alzheimer capability when docked with the receptors AChE and BChE with a binding affinity of -14.6 kcal/mol and -12.7 kcal/mol, respectively. Druglike nature, medicinal chemistry friendliness, and multiple toxicological were predicted using free SwissADME software.
No takes yet. Share an insight, caveat, or question.
Bhushan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: